Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Artificial Intelligence Ivd Market

ID: MRFR/HC/32943-HCR
100 Pages
Rahul Gotadki
Last Updated: April 13, 2026

Artificial Intelligence in IVD Market Research Report: Size, Share, Trend Analysis By Applications (Disease Diagnosis, Drug Discovand Bynomic Analysis, Radiology, Pathology), By End Use (Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies), By Technology (Machine Learning, Natural Language Processing, Computer Vision, Deep Learning), By Deployment Model (Cloud-Based, On-Premise, Hybrid) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Artificial Intelligence Ivd Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Application (USD Billion) | |
      1. 4.1.1 Disease Diagnosis | |
      2. 4.1.2 Drug Discovery | |
      3. 4.1.3 Genomic Analysis | |
      4. 4.1.4 Radiology | |
      5. 4.1.5 Pathology |
    2. 4.2 Healthcare, BY End-Use (USD Billion) | |
      1. 4.2.1 Hospitals | |
      2. 4.2.2 Diagnostic Laboratories | |
      3. 4.2.3 Research Institutes | |
      4. 4.2.4 Pharmaceutical Companies |
    3. 4.3 Healthcare, BY Technology (USD Billion) | |
      1. 4.3.1 Machine Learning | |
      2. 4.3.2 Natural Language Processing | |
      3. 4.3.3 Computer Vision | |
      4. 4.3.4 Deep Learning |
    4. 4.4 Healthcare, BY Deployment Model (USD Billion) | |
      1. 4.4.1 Cloud-Based | |
      2. 4.4.2 On-Premise | |
      3. 4.4.3 Hybrid |
    5. 4.5 Healthcare, BY Region (USD Billion) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Siemens Healthineers (DE) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Roche Diagnostics (CH) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Abbott Laboratories (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Thermo Fisher Scientific (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Danaher Corporation (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Becton Dickinson and Company (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Hologic, Inc. (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Bio-Rad Laboratories, Inc. (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 PerkinElmer, Inc. (US) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY APPLICATION |
    7. 6.4 US MARKET ANALYSIS BY END-USE |
    8. 6.5 US MARKET ANALYSIS BY TECHNOLOGY |
    9. 6.6 US MARKET ANALYSIS BY DEPLOYMENT MODEL |
    10. 6.7 CANADA MARKET ANALYSIS BY APPLICATION |
    11. 6.8 CANADA MARKET ANALYSIS BY END-USE |
    12. 6.9 CANADA MARKET ANALYSIS BY TECHNOLOGY |
    13. 6.10 CANADA MARKET ANALYSIS BY DEPLOYMENT MODEL |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY APPLICATION |
    16. 6.13 GERMANY MARKET ANALYSIS BY END-USE |
    17. 6.14 GERMANY MARKET ANALYSIS BY TECHNOLOGY |
    18. 6.15 GERMANY MARKET ANALYSIS BY DEPLOYMENT MODEL |
    19. 6.16 UK MARKET ANALYSIS BY APPLICATION |
    20. 6.17 UK MARKET ANALYSIS BY END-USE |
    21. 6.18 UK MARKET ANALYSIS BY TECHNOLOGY |
    22. 6.19 UK MARKET ANALYSIS BY DEPLOYMENT MODEL |
    23. 6.20 FRANCE MARKET ANALYSIS BY APPLICATION |
    24. 6.21 FRANCE MARKET ANALYSIS BY END-USE |
    25. 6.22 FRANCE MARKET ANALYSIS BY TECHNOLOGY |
    26. 6.23 FRANCE MARKET ANALYSIS BY DEPLOYMENT MODEL |
    27. 6.24 RUSSIA MARKET ANALYSIS BY APPLICATION |
    28. 6.25 RUSSIA MARKET ANALYSIS BY END-USE |
    29. 6.26 RUSSIA MARKET ANALYSIS BY TECHNOLOGY |
    30. 6.27 RUSSIA MARKET ANALYSIS BY DEPLOYMENT MODEL |
    31. 6.28 ITALY MARKET ANALYSIS BY APPLICATION |
    32. 6.29 ITALY MARKET ANALYSIS BY END-USE |
    33. 6.30 ITALY MARKET ANALYSIS BY TECHNOLOGY |
    34. 6.31 ITALY MARKET ANALYSIS BY DEPLOYMENT MODEL |
    35. 6.32 SPAIN MARKET ANALYSIS BY APPLICATION |
    36. 6.33 SPAIN MARKET ANALYSIS BY END-USE |
    37. 6.34 SPAIN MARKET ANALYSIS BY TECHNOLOGY |
    38. 6.35 SPAIN MARKET ANALYSIS BY DEPLOYMENT MODEL |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY END-USE |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY DEPLOYMENT MODEL |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY APPLICATION |
    45. 6.42 CHINA MARKET ANALYSIS BY END-USE |
    46. 6.43 CHINA MARKET ANALYSIS BY TECHNOLOGY |
    47. 6.44 CHINA MARKET ANALYSIS BY DEPLOYMENT MODEL |
    48. 6.45 INDIA MARKET ANALYSIS BY APPLICATION |
    49. 6.46 INDIA MARKET ANALYSIS BY END-USE |
    50. 6.47 INDIA MARKET ANALYSIS BY TECHNOLOGY |
    51. 6.48 INDIA MARKET ANALYSIS BY DEPLOYMENT MODEL |
    52. 6.49 JAPAN MARKET ANALYSIS BY APPLICATION |
    53. 6.50 JAPAN MARKET ANALYSIS BY END-USE |
    54. 6.51 JAPAN MARKET ANALYSIS BY TECHNOLOGY |
    55. 6.52 JAPAN MARKET ANALYSIS BY DEPLOYMENT MODEL |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY END-USE |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY DEPLOYMENT MODEL |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY END-USE |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY DEPLOYMENT MODEL |
    64. 6.61 THAILAND MARKET ANALYSIS BY APPLICATION |
    65. 6.62 THAILAND MARKET ANALYSIS BY END-USE |
    66. 6.63 THAILAND MARKET ANALYSIS BY TECHNOLOGY |
    67. 6.64 THAILAND MARKET ANALYSIS BY DEPLOYMENT MODEL |
    68. 6.65 INDONESIA MARKET ANALYSIS BY APPLICATION |
    69. 6.66 INDONESIA MARKET ANALYSIS BY END-USE |
    70. 6.67 INDONESIA MARKET ANALYSIS BY TECHNOLOGY |
    71. 6.68 INDONESIA MARKET ANALYSIS BY DEPLOYMENT MODEL |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY END-USE |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY DEPLOYMENT MODEL |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY APPLICATION |
    78. 6.75 BRAZIL MARKET ANALYSIS BY END-USE |
    79. 6.76 BRAZIL MARKET ANALYSIS BY TECHNOLOGY |
    80. 6.77 BRAZIL MARKET ANALYSIS BY DEPLOYMENT MODEL |
    81. 6.78 MEXICO MARKET ANALYSIS BY APPLICATION |
    82. 6.79 MEXICO MARKET ANALYSIS BY END-USE |
    83. 6.80 MEXICO MARKET ANALYSIS BY TECHNOLOGY |
    84. 6.81 MEXICO MARKET ANALYSIS BY DEPLOYMENT MODEL |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY END-USE |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY DEPLOYMENT MODEL |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USE |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEPLOYMENT MODEL |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY END-USE |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY DEPLOYMENT MODEL |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY END-USE |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY DEPLOYMENT MODEL |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY END-USE |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY DEPLOYMENT MODEL |
    106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF HEALTHCARE |
    109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
    112. 6.109 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
    113. 6.110 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
    114. 6.111 HEALTHCARE, BY END-USE, 2024 (% SHARE) |
    115. 6.112 HEALTHCARE, BY END-USE, 2024 TO 2035 (USD Billion) |
    116. 6.113 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE) |
    117. 6.114 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion) |
    118. 6.115 HEALTHCARE, BY DEPLOYMENT MODEL, 2024 (% SHARE) |
    119. 6.116 HEALTHCARE, BY DEPLOYMENT MODEL, 2024 TO 2035 (USD Billion) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY END-USE, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY DEPLOYMENT MODEL, 2025-2035 (USD Billion) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2025-2035)

  • Disease Diagnosis
  • Drug Discovery
  • Genomic Analysis
  • Radiology
  • Pathology

Healthcare By End-Use (USD Billion, 2025-2035)

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical Companies

Healthcare By Technology (USD Billion, 2025-2035)

  • Machine Learning
  • Natural Language Processing
  • Computer Vision
  • Deep Learning

Healthcare By Deployment Model (USD Billion, 2025-2035)

  • Cloud-Based
  • On-Premise
  • Hybrid

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions